Lifeward Ltd (LFWD)

$0.65 0.00 (-0.31%)
Market Cap 10.21M
Revenue (ttm) 25.66M
Net Income (ttm) -28.94M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -112.78%
Debt to Equity Ratio 0.00
Volume 242,700
Avg Vol 348,482
Day's Range N/A - N/A
Shares Out 15.71M
Stochastic %K 5%
Beta 0.19
Analysts Strong Sell
Price Target $8.00

Company Profile

Lifeward Ltd., a medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, the Asia-Pacific, and internationally. It offers ReWalk personal exoskeleton and rehabilitation exoskeleton devices; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke; AlterG Anti-Gra...

Industry: Medical Devices
Sector: Healthcare
Phone: 972 4 959 0123
Address:
3 Hatnufa Street, Floor 6, Yokneam Illit, Israel
Kjskms
Kjskms Oct. 24 at 1:33 PM
$LFWD Go to the bank and ask for a loan! I don't know if they'll lend money to the likes of you.
1 · Reply
Kjskms
Kjskms Oct. 24 at 8:46 AM
$LFWD Don't talk about rising without reason
0 · Reply
Awiz2
Awiz2 Oct. 23 at 11:41 AM
$LFWD Time to regain the $5 level
0 · Reply
Kjskms
Kjskms Oct. 23 at 9:28 AM
$LFWD Management, Board of Directors, listen up. At the next shareholders' meeting, all your proposals will be rejected. You suckers of shareholders' lifeblood.
0 · Reply
Klinsmann
Klinsmann Oct. 17 at 9:02 PM
$LFWD 👀 again
0 · Reply
Kjskms
Kjskms Oct. 17 at 7:51 PM
$LFWD What We’re Demanding: 1. Tie exec pay to real performance — revenue, cash flow, and less dilution. 2. Stock options only if the price holds above $2 with real results. 3. If they can’t execute, the Board must pursue M&A or a full sale.
0 · Reply
EvE12
EvE12 Oct. 16 at 11:18 PM
$LFWD Why did they publish the 8-K now? What could be the reason?
1 · Reply
Kjskms
Kjskms Oct. 16 at 9:03 PM
$LFWD Executives who are paid too much for the work they do!
0 · Reply
abira
abira Oct. 16 at 4:39 PM
$LFWD "The Company’s cash and cash equivalents as of September 30, 2025 was approximately $2.0 million" from their latest 8-K 😲
1 · Reply
HappyGentelmen
HappyGentelmen Oct. 16 at 11:15 AM
$LFWD New Report?
0 · Reply
Latest News on LFWD
First Commercial Medicare Advantage Plan Provides Payment for ReWalk 7 Personal Exoskeleton

Sep 9, 2025, 8:30 AM EDT - 6 weeks ago

First Commercial Medicare Advantage Plan Provides Payment for ReWalk 7 Personal Exoskeleton

Lifeward Achieves CE Mark Approval for the ReWalk 7 Personal Exoskeleton

Sep 8, 2025, 8:30 AM EDT - 6 weeks ago

Lifeward Achieves CE Mark Approval for the ReWalk 7 Personal Exoskeleton

Lifeward Ltd. (LFWD) Q2 2025 Earnings Call Transcript

Aug 14, 2025, 10:26 PM EDT - 2 months ago

Lifeward Ltd. (LFWD) Q2 2025 Earnings Call Transcript

Lifeward Ltd. Reports Second Quarter 2025 Financial Results

Aug 14, 2025, 8:00 AM EDT - 2 months ago

Lifeward Ltd. Reports Second Quarter 2025 Financial Results

Lifeward Names Almog Adar as New CFO, Strengthening Executive Leadership

Aug 13, 2025, 8:00 AM EDT - 2 months ago

Lifeward Names Almog Adar as New CFO, Strengthening Executive Leadership

Lifeward to Report Second Quarter Financial Results on August 14, 2025

Aug 7, 2025, 5:30 PM EDT - 2 months ago

Lifeward to Report Second Quarter Financial Results on August 14, 2025

Lifeward Expands Distribution Partnership with SportsMed Ltd. to Add Coverage for United Arab Emirates and Entire Gulf Cooperation Council Region

Aug 4, 2025, 8:30 AM EDT - 2 months ago

Lifeward Expands Distribution Partnership with SportsMed Ltd. to Add Coverage for United Arab Emirates and Entire Gulf Cooperation Council Region

MedRhythms Appoints Larry Jasinski as Chief Executive Officer to Lead Next Phase of Growth and Commercial Expansion

Jul 7, 2025, 11:00 AM EDT - 3 months ago

MedRhythms Appoints Larry Jasinski as Chief Executive Officer to Lead Next Phase of Growth and Commercial Expansion

Lifeward Announces Closing of $2.6 Million Public Offering

Jun 26, 2025, 4:15 PM EDT - 4 months ago

Lifeward Announces Closing of $2.6 Million Public Offering

Lifeward Announces Pricing of $2.6 Million Public Offering

Jun 25, 2025, 9:10 AM EDT - 4 months ago

Lifeward Announces Pricing of $2.6 Million Public Offering

Administrative Law Judge Determines ReWalk Personal Exoskeleton is “Reasonable and Necessary” for Medicare Beneficiary

Jun 24, 2025, 4:05 PM EDT - 4 months ago

Administrative Law Judge Determines ReWalk Personal Exoskeleton is “Reasonable and Necessary” for Medicare Beneficiary

Lifeward Names Mark Grant as New CEO

May 19, 2025, 8:30 AM EDT - 5 months ago

Lifeward Names Mark Grant as New CEO

Lifeward to Present at Sidoti Virtual Investor Conference on May 21

May 19, 2025, 6:00 AM EDT - 5 months ago

Lifeward to Present at Sidoti Virtual Investor Conference on May 21

Lifeward Ltd. (LFWD) Q1 2025 Earnings Call Transcript

May 15, 2025, 9:53 AM EDT - 5 months ago

Lifeward Ltd. (LFWD) Q1 2025 Earnings Call Transcript

Lifeward Ltd. Reports First Quarter 2025 Financial Results

May 15, 2025, 8:00 AM EDT - 5 months ago

Lifeward Ltd. Reports First Quarter 2025 Financial Results

Lifeward Completes Research Program with Israeli Human-Robot Interaction Consortium to Integrate Artificial Intelligence and Exoskeletons

May 8, 2025, 8:30 AM EDT - 6 months ago

Lifeward Completes Research Program with Israeli Human-Robot Interaction Consortium to Integrate Artificial Intelligence and Exoskeletons

Lifeward to Report First Quarter 2025 Financial Results on May 15, 2025

May 7, 2025, 4:30 PM EDT - 6 months ago

Lifeward to Report First Quarter 2025 Financial Results on May 15, 2025

First Major U.S. Commercial Health Insurer Approves Purchase of ReWalk 7 Personal Exoskeleton

Apr 29, 2025, 8:30 AM EDT - 6 months ago

First Major U.S. Commercial Health Insurer Approves Purchase of ReWalk 7 Personal Exoskeleton

Paralyzed Israeli Soldier Walks Again with Use of the ReWalk Personal Exoskeleton

Apr 24, 2025, 8:30 AM EDT - 6 months ago

Paralyzed Israeli Soldier Walks Again with Use of the ReWalk Personal Exoskeleton

Lifeward Launches Sales of the ReWalk 7 Personal Exoskeleton in U.S. Market

Apr 15, 2025, 8:15 AM EDT - 6 months ago

Lifeward Launches Sales of the ReWalk 7 Personal Exoskeleton in U.S. Market

FDA Issues Clearance for ReWalk 7 Exoskeleton

Mar 13, 2025, 9:15 AM EDT - 8 months ago

FDA Issues Clearance for ReWalk 7 Exoskeleton

Lifeward Ltd. (LFWD) Q4 2024 Earnings Call Transcript

Mar 7, 2025, 11:32 AM EST - 8 months ago

Lifeward Ltd. (LFWD) Q4 2024 Earnings Call Transcript

Lifeward Ltd. Reports Fourth Quarter and Full Year 2024 Financial Results

Mar 7, 2025, 8:00 AM EST - 8 months ago

Lifeward Ltd. Reports Fourth Quarter and Full Year 2024 Financial Results

Lifeward and CorLife Finalize Partnership to Expand Workers' Compensation Access to ReWalk Exoskeleton

Mar 6, 2025, 8:00 AM EST - 8 months ago

Lifeward and CorLife Finalize Partnership to Expand Workers' Compensation Access to ReWalk Exoskeleton

Lifeward and MYOLYN Expand Partnership to Enhance Patient Access to MyoCycle FES Cycling Therapy System for Home Use

Mar 5, 2025, 8:00 AM EST - 8 months ago

Lifeward and MYOLYN Expand Partnership to Enhance Patient Access to MyoCycle FES Cycling Therapy System for Home Use

Lifeward to Report Fourth Quarter and Fiscal Year-End 2024 Financial Results on March 7, 2025

Feb 28, 2025, 8:00 AM EST - 8 months ago

Lifeward to Report Fourth Quarter and Fiscal Year-End 2024 Financial Results on March 7, 2025

Lifeward Announces CEO Transition

Feb 19, 2025, 9:10 AM EST - 8 months ago

Lifeward Announces CEO Transition

Lifeward CEO Issues Year-End 2024 Open Letter to Shareholders and Provides 2025 Commercial and Operational Priorities

Jan 13, 2025, 8:30 AM EST - 10 months ago

Lifeward CEO Issues Year-End 2024 Open Letter to Shareholders and Provides 2025 Commercial and Operational Priorities

Lifeward Cancels Its Extraordinary General Meeting of Shareholders

Jan 13, 2025, 7:45 AM EST - 10 months ago

Lifeward Cancels Its Extraordinary General Meeting of Shareholders

Lifeward Announces Closing of $5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Jan 8, 2025, 4:15 PM EST - 10 months ago

Lifeward Announces Closing of $5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Lifeward Announces $5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Jan 7, 2025, 8:05 AM EST - 10 months ago

Lifeward Announces $5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Lifeward Announces Postponement of its Extraordinary General Meeting of Shareholders

Dec 27, 2024, 5:49 PM EST - 10 months ago

Lifeward Announces Postponement of its Extraordinary General Meeting of Shareholders

Coverage for ReWalk Personal Exoskeleton Expands as Hungary Joins the U.S. and Germany with a Policy Providing Access to Exoskeletons

Nov 19, 2024, 8:30 AM EST - 1 year ago

Coverage for ReWalk Personal Exoskeleton Expands as Hungary Joins the U.S. and Germany with a Policy Providing Access to Exoskeletons

Lifeward Ltd. (LFWD) Q3 2024 Earnings Call Transcript

Nov 12, 2024, 11:30 AM EST - 1 year ago

Lifeward Ltd. (LFWD) Q3 2024 Earnings Call Transcript

Lifeward Ltd. Reports Third Quarter 2024 Financial Results

Nov 12, 2024, 8:00 AM EST - 1 year ago

Lifeward Ltd. Reports Third Quarter 2024 Financial Results

Lifeward to Report Third Quarter Financial Results on November 12, 2024

Nov 5, 2024, 4:38 PM EST - 1 year ago

Lifeward to Report Third Quarter Financial Results on November 12, 2024

Lifeward Ltd. to Present at ThinkEquity Conference on Oct 30, 2024

Oct 24, 2024, 4:30 PM EDT - 1 year ago

Lifeward Ltd. to Present at ThinkEquity Conference on Oct 30, 2024

Lifeward Launches Direct Sales of AlterG Product Line in Germany

Sep 24, 2024, 5:00 PM EDT - 1 year ago

Lifeward Launches Direct Sales of AlterG Product Line in Germany

ReWalk Robotics Ltd. Finalizes Corporate Name Change to Lifeward Ltd.

Sep 12, 2024, 8:30 AM EDT - 1 year ago

ReWalk Robotics Ltd. Finalizes Corporate Name Change to Lifeward Ltd.

Lifeward Announces Appointment of Dr. Keith E. Tansey as Consulting Director of Clinical Research

Sep 10, 2024, 8:30 AM EDT - 1 year ago

Lifeward Announces Appointment of Dr. Keith E. Tansey as Consulting Director of Clinical Research

Lifeward's First Annual Step Challenge Donates €5,000 to German Association for People Living with Spinal Cord Injury

Sep 5, 2024, 8:30 AM EDT - 1 year ago

Lifeward's First Annual Step Challenge Donates €5,000 to German Association for People Living with Spinal Cord Injury

Lifeward to Present at the H.C. Wainwright 26th Annual Global Investment Conference

Sep 4, 2024, 4:15 PM EDT - 1 year ago

Lifeward to Present at the H.C. Wainwright 26th Annual Global Investment Conference

ReWalk Robotics Ltd. (LFWD) Q2 2024 Earnings Call Transcript

Aug 15, 2024, 1:07 PM EDT - 1 year ago

ReWalk Robotics Ltd. (LFWD) Q2 2024 Earnings Call Transcript

Lifeward to Report Second Quarter Financial Results on August 15, 2024

Aug 8, 2024, 4:15 PM EDT - 1 year ago

Lifeward to Report Second Quarter Financial Results on August 15, 2024

Lifeward Announces Appointment of Joseph E. Turk as Incoming Chairman of its Board of Directors

Jul 2, 2024, 4:30 PM EDT - 1 year ago

Lifeward Announces Appointment of Joseph E. Turk as Incoming Chairman of its Board of Directors

Lifeward Unveils Newest Addition to Its AlterG Anti-Gravity Product Line – Introducing AlterG NEO

Jun 26, 2024, 8:30 AM EDT - 1 year ago

Lifeward Unveils Newest Addition to Its AlterG Anti-Gravity Product Line – Introducing AlterG NEO

Lifeward to Present at Sidoti Virtual Investor Conference on June 12

Jun 4, 2024, 4:30 PM EDT - 1 year ago

Lifeward to Present at Sidoti Virtual Investor Conference on June 12

ReWalk Robotics Ltd. (LFWD) Q1 2024 Earnings Call Transcript

May 15, 2024, 1:06 PM EDT - 1 year ago

ReWalk Robotics Ltd. (LFWD) Q1 2024 Earnings Call Transcript

Lifeward Reports First Quarter 2024 Financial Results

May 15, 2024, 8:00 AM EDT - 1 year ago

Lifeward Reports First Quarter 2024 Financial Results

Lifeward to Report First Quarter Financial Results on May 15, 2024

May 7, 2024, 4:30 PM EDT - 1 year ago

Lifeward to Report First Quarter Financial Results on May 15, 2024

Kjskms
Kjskms Oct. 24 at 1:33 PM
$LFWD Go to the bank and ask for a loan! I don't know if they'll lend money to the likes of you.
1 · Reply
Kjskms
Kjskms Oct. 24 at 8:46 AM
$LFWD Don't talk about rising without reason
0 · Reply
Awiz2
Awiz2 Oct. 23 at 11:41 AM
$LFWD Time to regain the $5 level
0 · Reply
Kjskms
Kjskms Oct. 23 at 9:28 AM
$LFWD Management, Board of Directors, listen up. At the next shareholders' meeting, all your proposals will be rejected. You suckers of shareholders' lifeblood.
0 · Reply
Klinsmann
Klinsmann Oct. 17 at 9:02 PM
$LFWD 👀 again
0 · Reply
Kjskms
Kjskms Oct. 17 at 7:51 PM
$LFWD What We’re Demanding: 1. Tie exec pay to real performance — revenue, cash flow, and less dilution. 2. Stock options only if the price holds above $2 with real results. 3. If they can’t execute, the Board must pursue M&A or a full sale.
0 · Reply
EvE12
EvE12 Oct. 16 at 11:18 PM
$LFWD Why did they publish the 8-K now? What could be the reason?
1 · Reply
Kjskms
Kjskms Oct. 16 at 9:03 PM
$LFWD Executives who are paid too much for the work they do!
0 · Reply
abira
abira Oct. 16 at 4:39 PM
$LFWD "The Company’s cash and cash equivalents as of September 30, 2025 was approximately $2.0 million" from their latest 8-K 😲
1 · Reply
HappyGentelmen
HappyGentelmen Oct. 16 at 11:15 AM
$LFWD New Report?
0 · Reply
HappyGentelmen
HappyGentelmen Oct. 14 at 12:55 PM
$LFWD The Train will leave the Station... Get in before it´s to late! $BTC.X $NVDA $TSLA
1 · Reply
JamesMBMM
JamesMBMM Oct. 14 at 11:49 AM
$BAOS $LFWD 👍
0 · Reply
GJ_Rockabilt
GJ_Rockabilt Oct. 14 at 10:36 AM
$LFWD I believe The Rewalk Exoskeleton shows possible promise to many of those afflicted with Spina Bifida, so I'm very partial and biased towatds the success of Lifeward. Please, keep that in mind.
1 · Reply
GJ_Rockabilt
GJ_Rockabilt Oct. 14 at 10:27 AM
$LFWD I'm predicting Veterans Administration (VA) Hospitals will be big consumers of The ReWalk Exoskeleton in near future, now that EU has accepted latest Version. Veteran Spinal Cord Injury Technology - Lifeward https://share.google/UIRFNkjQqGI5dohZ3
0 · Reply
HappyGentelmen
HappyGentelmen Oct. 13 at 12:18 PM
$LFWD Let the Party started! $ 1 soon!
0 · Reply
makedatbread88
makedatbread88 Oct. 13 at 9:50 AM
$LFWD this sees $1+ soon
0 · Reply
Smug_Vortex
Smug_Vortex Oct. 10 at 5:05 PM
$ADAP $ALLR $APVO $CCG $CAPS $EONR $LFWD $NCNA Just another blood red Friday. Typical. Trump mouthing off about China doesn’t help, but stand strong. Hold on. Why take losses? Being a trader is about DD, courage and patience. Even a rookie knows Friday tons of people dump and sit back. Especially the big boys, who are manipulating the market for their own sinister agenda. You either scoop more cheap or just hold for the continuation upward. All these stocks are money makers. They have been and will be again.
0 · Reply
Donnystocks69
Donnystocks69 Oct. 9 at 5:45 PM
$LFWD almsot 10k shares. As long as this is under $1 im buying
0 · Reply
keitht007
keitht007 Oct. 9 at 3:16 PM
$LFWD Like watching paint dry. One day soon we will spike hard I believe
0 · Reply
REALOSCAR
REALOSCAR Oct. 9 at 2:43 PM
$LFWD who’s buying 7.5 calls for next week?😅
1 · Reply
REALOSCAR
REALOSCAR Oct. 9 at 2:24 PM
$LFWD Still holding strong at $0.82 with tight consolidation — this chart is coiling up for a potential breakout 💥 📊 Technical Setup: • Price riding right above the 9 EMA, showing strong trend support 📈 • MACD curling up again — momentum returning! 💪 • RSI around 53, plenty of room for another push higher 🚀 • Volume starting to tick up, indicating accumulation 💰 📍 Key Levels: • Support: $0.68 • Resistance: $0.88 (break above = confirmation of next leg) • Target zone: $1.10 – $1.20 🔥 💎 Summary: Buyers are clearly stepping back in, and sentiment around healthcare tech names remains strong. If we see volume pick up near the $0.88 area, this can move fast.
0 · Reply
REALOSCAR
REALOSCAR Oct. 9 at 10:06 AM
$EKSO $LFWD $MYO
1 · Reply